Go Pro

94,763 Shares in Cigna Group $CI Bought by Bruni J V & Co. Co.

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Bruni J V & Co. Co. acquired 94,763 Cigna shares during the second quarter, making the position about 2.4% of its portfolio. Institutional investors and hedge funds collectively own 86.99% of Cigna’s outstanding stock.
  • Analyst sentiment remains favorable, with 15 Buy ratings and seven Holds, producing a consensus “Moderate Buy” rating and a $339.45 price target. Recent target changes were mixed, including UBS raising its target to $400 and Piper Sandler cutting its target to $346.
  • Cigna beat quarterly earnings expectations with adjusted EPS of $7.78 versus the $7.60 consensus, while revenue rose 6.7% year over year to $70.04 billion. The company also declared a quarterly dividend of $1.56, equivalent to a 2.2% annual yield.
  • Five stocks to consider instead of Cigna Group.

Bruni J V & Co. Co. acquired a new stake in shares of Cigna Group (NYSE:CI - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 94,763 shares of the health services provider's stock, valued at approximately $26,124,264,000. Cigna Group comprises about 2.4% of Bruni J V & Co. Co.'s portfolio, making the stock its 18th largest position.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in Cigna Group during the fourth quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider's stock valued at $900,912,000 after purchasing an additional 3,141,844 shares during the period. Dodge & Cox lifted its stake in shares of Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock worth $3,065,681,000 after buying an additional 1,833,389 shares during the last quarter. Boston Partners boosted its holdings in shares of Cigna Group by 314.6% during the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider's stock worth $450,856,000 after buying an additional 1,243,056 shares during the period. Finally, GQG Partners LLC boosted its holdings in Cigna Group by 14.3% during the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider's stock valued at $2,136,699,000 after acquiring an additional 972,302 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm's stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CI. Wall Street Zen lowered Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. UBS Group upped their price target on Cigna Group from $375.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, May 22nd. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Piper Sandler lowered their price objective on shares of Cigna Group from $370.00 to $346.00 and set an "overweight" rating on the stock in a research note on Wednesday, June 3rd. Finally, Barclays boosted their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.

Check Out Our Latest Analysis on Cigna Group

Cigna Group Trading Up 1.3%

Cigna Group stock opened at $278.95 on Wednesday. The business has a 50 day moving average price of $285.41 and a two-hundred day moving average price of $281.36. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The stock has a market cap of $73.71 billion, a price-to-earnings ratio of 11.54, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group's payout ratio is 25.82%.

About Cigna Group

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines